MedTrace Logo

Retrospective Study of Outcomes With 3 mm Implant for Percutaneous BAHS Procedures

NCT06421766 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 234

Last updated 2025-07-31

No results posted yet for this study

Summary

This retrospective study is conducted to gain more knowledge on use and complications of 3mm long implants used in percutaneous (through the skin) bone-anchored hearing system (BAHS) surgeries in adults. Patients included have already been treated and recieved an implant with the wide diameter (Ø: 4.5 mm) design, either of 3- or 4mm length. The main purpose of the study is to investigate implant survival three months after implantation.

Conditions

Interventions

DEVICE

BAHS

Implantation of a percutaneous bone-anchored hearing system

Sponsors & Collaborators

  • Oticon Medical

    lead INDUSTRY

Principal Investigators

  • Dennis G Pappas, MD · Alabama Ear Specialists

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-08
Primary Completion
2024-09-25
Completion
2024-09-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06421766 on ClinicalTrials.gov